Biomarkers of Hypoxic-Ischemic Encephalopathy in Newborns
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
As neonatal intensive care has evolved, the focus has shifted from improving mortality alone to an effort to improve both mortality and morbidity. The most frequent source of neonatal brain injury occurs as a result of hypoxic-ischemic injury. Hypoxic-ischemic injury occurs in about 2 of 1,000 full-term infants and severe injured infants will have lifetime disabilities and neurodevelopmental delays. Most recently, remarkable efforts toward neuroprotection have been started with the advent of therapeutic hypothermia and a key step in the evolution of neonatal neuroprotection is the discovery of biomarkers that enable the clinician-scientist to screen infants for brain injury, monitor progression of disease, identify injured brain regions, and assess efficacy of neuroprotective clinical trials. Lastly, biomarkers offer great hope identifying when an injury occurred shedding light on the potential pathophysiology and the most effective therapy. In this article, we will review biomarkers of HIE including S100B, neuron specific enolase, umbilical cord IL-6, CK-BB, GFAP, myelin basic protein, UCHL-1, and pNF-H. We hope to contribute to the awareness, validation, and clinical use of established as well as novel neonatal brain injury biomarkers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gluckman, P. D., Wyatt, J. S., Azzopardi, D., Ballard, R., Edwards, A. D., Ferriero, D. M., Polin, R. A., Robertson, C. M., Thoresen, M., Whitelaw, A., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17946-x · Cited by 2,270
Threshold of metabolic acidosis associated with newborn complications
Low, J. A., Lindsay, B. G., & Derrick, E. J. (1997) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(97)70080-2 · Cited by 316 · cited 2×
“in about 2% of full-term infants and in nearly 60% of very low birth weight (premature) newborns (Mulligan et al., 1980; Giffard et al., 1990; Low et al., 1997).”
Background
Cited by
Hypoxic-Ischemic Encephalopathy: A Review for the Clinician
Douglas-Escobar, M., & Weiss, M. D. (2015) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2014.3269 · Cited by 778
Self-citationNeuroprotective Strategies after Neonatal Hypoxic Ischemic Encephalopathy
Dixon, B., Reis, C., Ho, W., Tang, J., & Zhang, J. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160922368 · Cited by 182
“that can be used along with the brain imaging, and long-term neuro-assessments [193,194].”
MethodZaigham, M., Lundberg, F., & Olofsson, P. (2017) · Early Human Development · doi:10.1016/j.earlhumdev.2017.07.015 · Cited by 45
Elias, M., Bliznyuk, N., Yasova Barbeau, D., Sukumar, S., Carlos Roig, J., Rajderkar, D., Sura, L., Wynn, J. L., & Weiss, M. D. (2026) · Frontiers in pediatrics · doi:10.3389/fped.2026.1743749
“Additionally, our study’s stratification approach offers insights into metabolic and coagulation profiles, contributing to the growing body of literature on the importance of contextualizing laboratory values within the clinical presentation of HIE (3, 4, 17, 25–27).”
Self-citation
Metadata
- Authors
- Douglas-Escobar, M., & Weiss, M. D.
- Venue
- Frontiers in Neurology
- Publisher
- Frontiers Media SA
- Published
- 2012
- Volume
- 3
- Pages
- 144-144
- ISSN
- 1664-2295 (ISSN-L)
- OpenAlex
- W2159473136
- Cited by
- 125
- References
- 2
- FWCI
- 5.07
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Biomarkers of Hypoxic-Ischemic Encephalopathy in Newborns. https://app.cochat.ai/papers/10.3389/fneur.2012.00144
- The paper
- Douglas-Escobar, M., & Weiss, M. D. (2012). Biomarkers of Hypoxic-Ischemic Encephalopathy in Newborns. Frontiers in Neurology. https://doi.org/10.3389/fneur.2012.00144
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.